cystic fibrosis

April 15, 2021April 15, 2021

Claire’s Place Foundation Launches Website to Connect CF Community

cystic fibrosis, News

To mark its 10th anniversary, Claire’s Place Foundation has launched a website that seeks to connect the community of people affected by cystic fibrosis (CF). “Our new website is a ... Read more

April 13, 2021April 13, 2021

CF Therapy’s Effectiveness With Rare Mutations Can Be Determined in Lab

cystic fibrosis, News

An ex vivo technique using nasal epithelial cells from a young girl carrying a rare mutation profile for cystic fibrosis (CF) was successful at predicting the efficacy of an approved ... Read more

April 8, 2021April 8, 2021

Trial Testing Personalized Chest Physiotherapy System for Mucus Clearance

cystic fibrosis, News

A clinical trial underway in Israel is investigating how well a personalized chest physiotherapy system compares with traditional airway clearance techniques in people with cystic fibrosis (CF) and other chronic lung ... Read more

April 6, 2021April 6, 2021

Olgram Raises $1.77M to Develop New Class of Antibiotics Against Resistant Bacteria

cystic fibrosis, News

Olgram has raised €1.5 million (about $1.77 million) in seed funding from investors to speed its development of antibiotics to clear persistent bacteria responsible for chronic, repeat infections. The company’s ... Read more

April 1, 2021April 1, 2021

New LungQ Software Can Analyze CF Airway Problems in Seconds, Thirona Says

cystic fibrosis, News

Thirona announced it has developed a new software program that can quickly detect and quantify lung anomalies in cystic fibrosis (CF) patients, including those beyond the capacity of a doctor ... Read more

March 30, 2021March 30, 2021

Australia Approves Trikafta for Patients, 12 and Older, With Common Mutation

cystic fibrosis

Health regulators in Australia have approved Trikafta (elexacaftor/tezacaftor/ivacaftor) to treat people with cystic fibrosis (CF), ages 12 years and older, who have at least one copy of the F508del mutation ... Read more

March 26, 2021March 26, 2021

Trikafta Found Safe, Effective for Children Ages 6–11

cystic fibrosis

Trikafta, a medication that combines three different therapies (elexacaftor/tezacaftor/ivacaftor), is safe and effective in children with cystic fibrosis (CF) ages 6 to 11 who have certain genetic mutations, results from ... Read more

March 25, 2021March 25, 2021

CF Families in Ontario Send Video Plea for Access to Vertex Therapies

cystic fibrosis

Parents of children and young adults with cystic fibrosis (CF) in Ontario sent a video appeal to the head of their province’s government, asking the premier to quickly expand prescription ... Read more

March 23, 2021March 23, 2021

Translate Bio’s MRT5005 Shows Safety and Tolerability at Multiple Doses in Trial

cystic fibrosis, News

Translate Bio’s ongoing Phase 1/2 clinical trial investigating MRT5005, its candidate inhalation therapy for cystic fibrosis (CF), found that repeat dosing is generally safe and well-tolerated. MRT5005 is designed to treat ... Read more

March 19, 2021March 19, 2021

Computer-designed Enzyme May Help to Kill P. aeruginosa in Biofilms

cystic fibrosis

An enzyme produced using computer design, in combination with the antibiotic tobramycin, efficiently kills Pseudomonas aeruginosa, a pathogen that often infects the lungs of patients with cystic fibrosis (CF), a ... Read more

Join our email list!